🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of the study is to investigate the effects of high-dose...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2013-12
Trial ID
NCT01886287
Treatments Being Tested
This is a Phase II, open-label multicentre, randomised study to assess the ...
Status
Completed
Location
Hospices Civils de Lyon
Start Date
2015-01
Trial ID
NCT02299089
Treatments Being Tested
The purpose of this study is to determine whether long-acting octreotide is...
Status
Unknown
Location
Radboudumc
Start Date
2016-10
Trial ID
NCT02874326
Treatments Being Tested
The aim of the study is to clarify whether octreotide therapy can reduce un...
Status
Completed
Location
Karolinska University Hospital, Huddinge
Start Date
2021-06-16
Trial ID
NCT04871204
Treatments Being Tested
Currently, the first line treatment for acromegaly is surgery, in order to ...
Status
Completed
Location
Multiple Locations
Start Date
2002-11
Trial ID
NCT00225979
Treatments Being Tested
This randomized phase III trial studies octreotide acetate and recombinant ...
Status
Active Not Recruiting
Location
Providence Hospital
Start Date
2007-12-01
Trial ID
NCT00569127
Treatments Being Tested
This phase I trial studies the side effects and best dose of cixutumumab wh...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2010-10
Trial ID
NCT01204476
Treatments Being Tested
The goal of this clinical trial is to investigate the synergistic effect of...
Status
Completed
Location
Chuncheon Sacred Heart Hospital
Start Date
2014-11-20
Trial ID
NCT06753630
This clinical trial compares a combination of two drugs that constrict bloo...
Status
Completed
Location
VA Connecticut Health Care System (West Haven)
Start Date
2003-12
Trial ID
NCT00108355
To evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) response of a...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT00913055
Treatments Being Tested